Sharp Services, a leader in pharmaceutical packaging, clinical trial services & sterile manufacturing, has appointed Samantha Wilson Jones as General Counsel and Corporate Secretary of Sharp.
In her role as General Counsel, Samantha will join Sharp’s Senior Leadership Team and report directly to Kevin Orfan, CEO & President. She takes responsibility for Sharp’s legal function globally, including corporate compliance, risk management and EHS. She will advise Sharp’s SLT and the Board of Directors on legal, regulatory, compliance, and corporate governance matters.
Samantha brings to Sharp almost thirty years of knowledge and experience in legal, corporate and commercial affairs specifically in the life sciences industry, having held senior leadership positions at GSK, Incyte Corporation and, most recently, Spark Therapeutics where she served as Chief of Staff and Chief Legal Officer.
Commenting on Samantha’s appointment, CEO & President Kevin Orfan said: “I am delighted to welcome Samantha to Sharp to lead what is a critical function for our business. Her legal experience across a broad range of sectors including commercial, regulatory, governance and corporate development will be of tremendous value in helping guide Sharp as we continue to grow by supporting our pharmaceutical and biotech clients and their patients.
“I am honored to join Sharp, a company I’ve known since the early days of my career in the life sciences industry. Their purpose—to help make lives better—deeply resonates with me, and I look forward to contributing to advancing this important work alongside such a dedicated team”, said Samantha.
Samantha, who will be based at Sharp’s headquarters in Allentown PA, holds a BSc in International Studies and Political Science from Drexel University, a Juris Doctor (JD) and an LLM in Health Law both from Widener University School of Law and an Executive MBA from Drexel University LeBow College of Business.
About Sharp
Sharp is a leader in commercial packaging, clinical services & sterile manufacturing. For 70+ years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium & the Netherlands and 30+ clinical depots globally, covering every region of the world, our experience is your strength.
Our full complement of integrated services includes research and development, clinical manufacturing, sterile development and fill/finish services, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage, distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of drug product release in the EU and UK.
For more information on Sharp and its solutions, visit www.sharpservices.com or follow us on LinkedIn.
